source Post navigation Poxel Announces the Grant of Patent in China Protecting the Use of Imeglimin for Type-2 Diabetic Patients with Renal Impairment – Business Wire European Medicines Agency Investigating GLP-1 Drugs and Eye Disease – TCTMD